Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
136.87
+6.56 (5.03%)
Nov 1, 2024, 4:00 PM EDT - Market closed
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.58B in the quarter ending July 31, 2024, a decrease of -5.62%. This brings the company's revenue in the last twelve months to $6.50B, down -7.11% year-over-year. In the fiscal year ending October 31, 2023, Agilent Technologies had annual revenue of $6.83B, down -0.22%.
Revenue (ttm)
$6.50B
Revenue Growth
-7.11%
P/S Ratio
6.15
Revenue / Employee
$358,950
Employees
18,100
Market Cap
39.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
| Oct 31, 2019 | 5.16B | 249.00M | 5.07% |
| Oct 31, 2018 | Pro | Pro | Pro |
| Oct 31, 2017 | Pro | Pro | Pro |
| Oct 31, 2016 | Pro | Pro | Pro |
| Oct 31, 2015 | Pro | Pro | Pro |
| Oct 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical | 27.43B |
| GE HealthCare Technologies | 19.56B |
| IQVIA Holdings | 15.32B |
| Haleon | 15.07B |
| Edwards Lifesciences | 6.31B |
| ResMed | 4.81B |
| IDEXX Laboratories | 3.84B |
| Veeva Systems | 2.57B |
A News
- 1 day ago - Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Benzinga
- 12 days ago - Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series - Business Wire
- 16 days ago - Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25 - Business Wire
- 4 weeks ago - Agilent to Host Analyst and Investor Day on Dec. 17, 2024 - Business Wire
- 5 weeks ago - H.I.G. Capital Completes the Sale of BIOVECTRA - Business Wire
- 6 weeks ago - Agilent Completes Acquisition of BIOVECTRA - Business Wire
- 6 weeks ago - Agilent Announces Cash Dividend of 23.6 Cents per Share - Business Wire
- 7 weeks ago - Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine - Business Wire